Siemens furthers particle therapy development

Article

Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience

Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience in particle accelerator technology. GSI is a government-funded heavy ion research center located in Darmstadt, Germany. Particle therapy treatments utilize fast-moving atomic particles such as ions or protons. Treatments can be focused with pinpoint accuracy, thereby lowering integral dose and reducing toxicity to healthy tissues.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.